TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|13|9|1215-1221

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.9, 2012-08, pp. : 1215-1221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases

By  

Current Drug Targets, Vol. 13, Iss. 8, 2012-07 ,pp. : 1089-1095

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

By Hu Erding   Lee Dennis  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 715-736

Informa Healthcare

Access to resources Recommend Favorite

Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases

By Broadley K.J.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1669-1692

Informa Healthcare

Access to resources Recommend Favorite

Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 13, Iss. 8, 2007-03 ,pp. : 845-863

Bentham Science Publishers

Access to resources Recommend Favorite